Kestra expects $137M FY2027 revenue while targeting 70%+ gross margins in the next few years (NASDAQ:KMTS)July 15, 2026
Share Facebook Twitter LinkedIn Pinterest Email Notable healthcare headlines for the week: Eli Lilly, UnitedHealth, and Boston Scientific in focus
Kestra expects $137M FY2027 revenue while targeting 70%+ gross margins in the next few years (NASDAQ:KMTS)July 15, 2026